Zeaxanthin for Skin & Brain

The hippocampus, a memory centre of the brain
The hippocampus, a memory centre of the brain
Forearm showing sun exposure on skin
Forearm showing sun exposure on skin
Goji berries growing, a rich zeaxanthin source
Goji berries growing, a rich zeaxanthin source

The eye is where zeaxanthin's evidence is strongest, but it is not the only place the body puts it. Carotenoids also deposit in the skin, where they contribute to the skin's own antioxidant defense, and in the brain, where lutein and zeaxanthin are among the dominant carotenoids in neural tissue. Both fields are genuinely interesting and both are, at this stage, more promising than proven. This page reviews the real human trials on skin photoprotection and on cognition — and is deliberately clear about where the science is still preliminary.


Table of Contents

  1. Zeaxanthin Beyond the Eye
  2. Carotenoids Accumulate in Skin
  3. Skin Photoprotection: What Trials Show
  4. Hydration, Elasticity and Appearance
  5. Honest Limits on Skin Claims
  6. The Brain Concentrates Lutein and Zeaxanthin
  7. Macular Pigment and Cognition
  8. The Cognitive Trials
  9. Early Life: Infant Eyes and Brain
  10. Honest Limits on Brain Claims
  11. Key Research Papers
  12. Connections
  13. Featured Videos

Zeaxanthin Beyond the Eye

Once absorbed, zeaxanthin and lutein circulate in the blood on lipoproteins and are taken up by tissues throughout the body. Two non-ocular sites stand out because the pigments accumulate there in meaningful amounts and because there is a plausible biological reason for a benefit: the skin, our largest organ and our first barrier against ultraviolet light, and the brain, where these carotenoids are selectively enriched in gray matter. In both places the underlying logic is the same as in the eye — carotenoids are lipid-soluble antioxidants and light/oxidative-stress buffers — but the strength of evidence is a step below the ocular data.

Back to Table of Contents

Carotenoids Accumulate in Skin

Dietary carotenoids, including zeaxanthin and lutein, deposit in the skin, and skin carotenoid levels can be measured non-invasively (for example by resonance Raman spectroscopy) as a marker of fruit-and-vegetable intake. Studies comparing skin and blood levels (Meinke 2010) confirm that what you eat reaches the dermis and epidermis. Reviews of carotenoids in eye and skin health (Roberts 2009) describe how these pigments join vitamin E and other lipophilic antioxidants in the skin's defense network against reactive oxygen species generated by sunlight.

Back to Table of Contents

Skin Photoprotection: What Trials Show

The idea that dietary carotenoids can raise the skin's resistance to ultraviolet (UV) damage has real, if modest, experimental support:

The consistent theme is that dietary carotenoids give the skin a small internal buffer against ultraviolet oxidative stress — useful and real, but far weaker than a topical sunscreen with a proper sun protection factor (SPF).

Back to Table of Contents

Hydration, Elasticity and Appearance

Beyond sunburn thresholds, some small trials have looked at skin quality measures. The Palombo study (2007) reported improvements in skin hydration and elasticity as well as surface lipids with combined lutein/zeaxanthin treatment. A review of carotenoid skin-protective effects (Balic 2019) catalogs the mechanisms — antioxidant quenching, reduced lipid peroxidation, modulation of ultraviolet-induced inflammation — that could plausibly translate into better-appearing, better-protected skin over time.

These findings come from small studies, some with a topical component, so they are supportive rather than definitive. They fit with a diet rich in colorful carotenoid-bearing vegetables adding to the skin's overall antioxidant status; they do not show that a zeaxanthin pill is a proven anti-aging or anti-wrinkle treatment.

Back to Table of Contents

Honest Limits on Skin Claims

Back to Table of Contents

The Brain Concentrates Lutein and Zeaxanthin

One of the more surprising discoveries of the last two decades is that the human brain selectively accumulates carotenoids — and that lutein and zeaxanthin, not the more abundant beta-carotene, are among the dominant ones in neural tissue. Analyses of human brain samples have found that lutein in particular is preferentially concentrated relative to its share of blood carotenoids, suggesting the brain actively takes it up. Because the retina is developmentally an outgrowth of the brain and uses the same pigments, macular pigment can serve as a convenient, measurable window onto brain carotenoid status.

A caveat worth stating up front: within the brain, lutein is generally the dominant of the two, with zeaxanthin present in smaller amounts. So brain research is largely a lutein-and-zeaxanthin story in which zeaxanthin is the junior partner — the reverse of the situation at the foveal center. For a fuller treatment of the cognitive research, see our companion Lutein Benefits pages.

Zeaxanthin may still matter in the brain. Johnson's 2012 review describes brain tissue from people who had taken part in a population-based study of centenarians: the amount of zeaxanthin in the brain was significantly related to overall thinking ability, memory retention, verbal fluency and dementia severity measured before death, after adjustment for age, sex, education, high blood pressure and diabetes. Lutein was related to recall and verbal fluency, but those links weakened after the same adjustments; lutein levels were, however, significantly lower in people with mild cognitive impairment than in people with normal thinking. These are associations and do not prove that the carotenoids caused the differences.

Back to Table of Contents

Macular Pigment and Cognition

Because macular pigment reflects brain carotenoid status, researchers have asked whether people with denser macular pigment also perform better cognitively. Several observational studies say yes. Vishwanathan (2014) found that macular pigment optical density was related to cognitive function in older people; Renzi (2014) reported associations between macular pigment and cognition in both unimpaired and mildly cognitively impaired older adults; and Ajana (2018) and Kelly (2015) linked plasma lutein/zeaxanthin and macular pigment to cognitive performance. Johnson's 2012 review summarized the early evidence for a role of lutein and zeaxanthin in cognitive function in the elderly — epidemiologic studies, macula and brain measurements in non-human primates, brain tissue from a centenarian study and a 4-month supplementation trial in older women — and was later expanded into a lifespan review (Johnson 2014).

These are associations, and associations cannot prove that the carotenoids cause the better cognition — people who eat more leafy greens differ in many ways from those who do not. That is why the randomized trials matter.

Back to Table of Contents

The Cognitive Trials

A handful of randomized controlled trials have tested lutein and zeaxanthin supplementation on cognition, with modestly encouraging but not uniform results:

The overall picture is of small-to-moderate benefits in specific cognitive domains (memory, learning, attention, processing speed), most evident in people starting from low carotenoid status. It is a promising and internally consistent body of work — but the effects are modest, the trials are relatively small, and none show that zeaxanthin prevents dementia.

Back to Table of Contents

Early Life: Infant Eyes and Brain

Lutein and zeaxanthin are present in breast milk and accumulate in the developing retina and brain, which has prompted interest in their role in early neural development. Overviews of pediatric carotenoid biology (Gazzolo 2021) describe lutein's accumulation in maturing eyes and brain, and primate studies (Jeon 2018) show that dietary lutein is deposited across specific brain regions differently depending on feeding. In the primate study, infant rhesus monkeys were breastfed or given one of two formulas from birth to 6 months of age. Zeaxanthin was found in every brain region, but only in the breastfed infants; lutein was highest in the occipital cortex (the area that handles vision) whatever the diet; and formula with added carotenoids raised tissue lutein compared with unsupplemented formula but still left it well below breastfed levels. This is an animal study.

In premature infants, lutein and zeaxanthin have been studied for possible protection against retinopathy of prematurity (ROP, an eye disease of premature babies). A 2025 Cochrane review (Choo 2025) pooled 5 trials with 666 preterm infants, all run in Italy and the USA, that gave lutein and zeaxanthin together. Supplementation probably reduces ROP of stage 3 and above (risk ratio 0.49, 95% confidence interval 0.29 to 0.81; moderate-certainty evidence), but probably has little or no effect on ROP of any stage (risk ratio 0.90), and may have little or no effect on deaths during the neonatal intensive care stay, bleeding into the brain's ventricles (intraventricular haemorrhage) or necrotising enterocolitis (a serious bowel disease of premature babies). No adverse effects were reported in either group. The authors note that the pooled estimates may change with further rigorously conducted trials.

Back to Table of Contents

Honest Limits on Brain Claims

Back to Table of Contents

Key Research Papers

  1. Roberts RL, Green J, Lewis B (2009). Lutein and zeaxanthin in eye and skin health. Clinics in Dermatology — PubMed PMID: 19168000
  2. Palombo P et al. (2007). Beneficial long-term effects of combined oral/topical antioxidant treatment with the carotenoids lutein and zeaxanthin on human skin. Skin Pharmacology and Physiology — PubMed PMID: 17446716
  3. Heinrich U et al. (2003). Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema. Journal of Nutrition — PubMed PMID: 12514275
  4. Stahl W, Sies H (2002). Carotenoids and protection against solar UV radiation. Skin Pharmacology and Applied Skin Physiology — PubMed PMID: 12239422
  5. Meinke MC et al. (2010). Bioavailability of natural carotenoids in human skin compared to blood. European Journal of Pharmaceutics and Biopharmaceutics — PubMed PMID: 20558286
  6. Johnson EJ (2012). A possible role for lutein and zeaxanthin in cognitive function in the elderly. American Journal of Clinical Nutrition — PubMed PMID: 23053547
  7. Lindbergh CA et al. (2018). Lutein and zeaxanthin influence brain function in older adults: a randomized controlled trial. Journal of the International Neuropsychological Society — PubMed PMID: 28695791
  8. Power R et al. (2018). Supplemental retinal carotenoids enhance memory in healthy individuals with low levels of macular pigment: a randomized, double-blind, placebo-controlled trial. Journal of Alzheimer's Disease — PubMed PMID: 29332050
  9. Lopresti AL et al. (2022). The effects of lutein and zeaxanthin supplementation on cognitive function in adults with self-reported mild cognitive complaints. Frontiers in Nutrition — PubMed PMID: 35252311
  10. Vishwanathan R et al. (2014). Macular pigment optical density is related to cognitive function in older people. Age and Ageing — PubMed PMID: 24435852
  11. Gazzolo D et al. (2021). Early pediatric benefit of lutein for maturing eyes and brain — an overview. Nutrients — PubMed PMID: 34579116
  12. Choo YM et al. (2025). Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews — PubMed PMID: 40292760
  13. Jeon S, Ranard KM, Neuringer M, Johnson EE, Renner L, Kuchan MJ, Pereira SL, Johnson EJ, Erdman JW Jr (2018). Lutein Is Differentially Deposited across Brain Regions following Formula or Breast Feeding of Infant Rhesus Macaques. Journal of Nutrition 148(1):31-39 — PubMed PMID: 29378053
  14. Natarelli N, Aflatooni S, Stankiewicz K, Correa-Selm L, Sivamani RK (2025). Oral Supplements and Photoprotection: A Systematic Review. Journal of Medicinal Food 28(6):519-541 — PubMed PMID: 39804624
  15. Johnson EJ (2014). Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan. Nutrition Reviews 72(9):605-12 — PubMed PMID: 25109868

PubMed Topic Searches

  1. PubMed: Skin photoprotection
  2. PubMed: Carotenoids and UV erythema
  3. PubMed: L/Z and cognition
  4. PubMed: Macular pigment and brain
  5. PubMed: Brain carotenoid accumulation

External Resources

  1. Linus Pauling Institute — Carotenoids
  2. NIH Office of Dietary Supplements — Fact Sheets
  3. American Academy of Dermatology — Sun Protection

Back to Table of Contents

Connections

Back to Table of Contents